Ray Prudo - Significant Ownership

Signature - Title
Ray Prudo, M.D. - Reporting Person
Location
London, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ray Prudo.

Significant Ownership of Ray Prudo

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AKTX Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value 9.3% $4.48B 4.93B Ray Prudo, M.D. Nov 14, 2024

Schedules 13D/G Reported by Ray Prudo:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.